RxDoctor Payments Data

Terrell Phillips, DO

Pain Management · Oklahoma City, OKNPI 1871534024

Payments from drug & device makers

$30,519in general payments, 2019–2025

Across 448 payments — averaging $68.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$20K
  • Abbott$3K
  • Relievant Medsystems, Inc.$802
  • Stratus Medical, LLC$796
  • Genesys Orthopedics Systems, L.L.C.$620
  • Avanos Medical$602
  • plus $5K from 41 others

What the payments were for

  • Speaking & faculty fees$16,80055%
  • Travel & lodging$2,2367%
  • Food & beverage$11,48338%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pain management providers in Oklahomato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$145,712
Medicare patients
306
Services billed
2,126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen653$50,165
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,365$43,344
BelbucaBuprenorphine Hcl52$38,284
Buprenorphine115$27,666
BelsomraSuvorexant39$19,360
GraliseGabapentin12$16,066
LinzessLinaclotide25$14,099
Xtampza ErOxycodone Myristate25$13,736
NucyntaTapentadol Hcl11$12,900
Nucynta ErTapentadol Hcl17$12,439
SymproicNaldemedine Tosylate21$9,433
ZtlidoLidocaine12$8,509
MovantikNaloxegol Oxalate20$7,853
Hysingla ErHydrocodone Bitartrate14$6,864
Lidocaine69$6,641

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta, Nucynta Er$584$77,359105 claims
MerckBelsomra$27$19,36039 claims
Almatica Pharma LLCGralise$15$16,06612 claims
AbbVieLinzess$73$14,09925 claims
Shionogi IncSymproic$45$9,43321 claims
Scilex Pharmaceuticals Inc.Ztlido$111$8,50912 claims
Redhill Biopharma Inc.Movantik$81$7,85320 claims
Eisai Inc.Dayvigo$96$4,88011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few pain management providers in Oklahomaon file to place this against a meaningful peer group, so we don't.

Other pain management in Oklahoma City

Where these figures come from

Is this you, or does something look wrong? →